About Arkin Holdings
Arkin Holdings is a venture capital firm founded in 2009. It is primarily based out of Herzliya, Israel. As of Apr 2026, Arkin Holdings is an active investor, having invested in 56 companies, with 2 new investments in the last 12 months. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Enterprise Applications. Most recently it participated in the $***** Post IPO round of Stark Power Overall, Arkin Holdings portfolio has seen 5 IPOs and 16 acquisitions including key companies like Keros Therapeutics, Validic and MedMinder Systems. A lot of funds co-invest with Arkin Holdings, with names like Pontifax sharing a substantial percentage of its portfolio. Arkin Holdings has team of 13 people including 5 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Seed & 3 more
Portfolio Soonicorns
Deals in last 12 months
Arkin Holdings' List of Top Investments
Arkin Holdings has a portfolio of 56 companies. Their most notable investments are in Auron Therapeutics and Fu-Gen.Their portfolio spans across Israel, United States, Canada and 1 more locations. They have invested in Life Sciences, High Tech, Enterprise Applications and 14 other sectors, across stages such as Series A, Seed and 3 more. Here is the list of top investments by Arkin Holdings:
1. Eleos Health
AI-based behavioral health diagnosis and management system for providers. The company's technology works as an ambient scribe integrating seamlessly with existing workflows and electronic health records via a browser extension. I simplifies documentation, speeding note submission, and enhancing audit compliance via AI-driven flagging of issues.
Key facts about Eleos Health
- Founded Year: 2019
- Location: Boston (United States)
- Stage: Series C
- Total Funding till date: $126M
- Employee Count: 289 as on May 31, 2026
- Investors: Menlo Ventures, Eight Roads Ventures and 16 Others
- Latest Funding Round: Series C, Jan 22, 2025, $*****
- Highlight: Editors' Pick
2. Mindspace
Provider of managed co-working spaces. The platform enables users to find personalized and managed co-working spaces. Also, landlords can host/share the property for clients and claim to get earn from it.
Key facts about Mindspace
- Founded Year: 2013
- Location: Tel Aviv (Israel)
- Valuation: $*****
- Stage: Series C
- Total Funding till date: $107M
- Employee Count: 446 as on May 31, 2026
- Investors: Arkin Holdings, Harel Group and 8 Others
- Latest Funding Round: Series C, Nov 24, 2021, $*****
- Highlight: Editors' Pick
Keros Therapeutics is developing small molecules and biologics for rare neuromuscular and hematologic diseases. The product pipeline involves KER-050 to treat myelodysplastic syndrome and myelofibrosis (phase II); KER-047 to treat hepcidin-cased anemia and fibrodysplasia ossificans progressive (FOP); KER-012 to treat pulmonary arterial hypertension and bone disorders.
Key facts about Keros Therapeutics
- Founded Year: 2016
- Location: Lexington (United States)
- Annual Revenue: $100M - $500M as on Dec 31, 2025
- Stage: Public
- Total Funding till date: $90M
- Employee Count: 125 as on May 31, 2026
- Investors: Foresite Capital, Venrock and 9 Others
- Latest Funding Round: Series C, Mar 04, 2020, $*****
- Highlight: Public
AI-based comparison platform for real estate insurance. It offers insurance quotes for commercial property, workers' compensation, commercial general liability, excess liability, crime, and more. It offers a comparison platform for property managers, building owners, homeowner associations, and developers.
Key facts about Honeycomb Insurance
- Founded Year: 2019
- Location: Denver (United States)
- Stage: Series C
- Total Funding till date: $94.7M
- Employee Count: 200 as on May 31, 2026
- Investors: Ibex Investors, Launchbay Capital and 16 Others
- Latest Funding Round: Series C, Jun 04, 2026, $*****
- Highlight: Editors' Pick
5. Validic
Provider of a single platform that aggregates data from multiple health device connections. It is a cloud-based technology platform that connects patient-recorded data from digital health applications, devices, and wearables to key healthcare companies like hospital systems, providers, pharmaceutical companies, payers, health information technology platforms, health clubs, and wellness companies.
Key facts about Validic
- Founded Year: 2010
- Location: Durham (United States)
- Stage: Acquired
- Total Funding till date: $31.6M
- Employee Count: 69 as on May 31, 2026
- Investors: Greycroft, Kaiser Permanente Ventures and 14 Others
- Latest Funding Round: Series B, Nov 14, 2022, $*****
- Highlight: Acquired
Arkin Holdings' Year-on-Year Investment Trends
Arkin Holdings has invested in 56 companies over the last 15 years, with an average of 3 new investments annually in the last 10 years. In 2025, it made 4 investments, while as of Apr 2026, it has made 1 investment in this year. Its most recent first time investment was in Stark Power and most recent follow-on round was in Rhino.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 1 | 0 | 1 |
2025 | 2 | 2 | 4 |
2024 | 6 | 2 | 8 |
2023 | 4 | 3 | 7 |
2022 | 6 | 3 | 9 |
2021 | 5 | 1 | 6 |
2020 | 6 | 3 | 9 |
2019 | 1 | 1 | 2 |
2018 | 1 | 0 | 1 |
2017 | 1 | 0 | 1 |
Arkin Holdings' Investments by Stage
Arkin Holdings has made 17 investments in Series A stage with an average round size of $40M, 11 investments in Seed stage with an average round size of $6.11M, 7 investments in Series B stage with an average round size of $37.4M, 2 investments in Series C stage with an average round size of $56M and 1 investment in Post IPO stage with an average round size of $70M.Stage of entry | No. of Investments |
|---|---|
Series A | 17 |
Seed | 11 |
Series B | 7 |
Series C | 2 |
Post IPO | 1 |
Note: We have considered here, only first round of investments
Arkin Holdings' Investments by Sector
Arkin Holdings has a diverse portfolio, with companies operating in the Life Sciences, High Tech, Enterprise Applications, HealthTech and Consumer. Notably, it has invested in 50 Enterprise (B2B) companies, 50 Tech companies, 14 Software companies and at least 12 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Life Sciences | 22 |
High Tech | 9 |
Enterprise Applications | 8 |
HealthTech | 8 |
Consumer | 4 |
Others | 21 |
Note: We have considered here, only first round of investments
Arkin Holdings' Investments by Geography
Arkin Holdings has made most investments in United States (20), followed by Israel where it has made 16 investments.Country | No. of Investments |
|---|---|
United States | 20 |
Israel | 16 |
Canada | 1 |
Switzerland | 1 |
Note: We have considered here, only first round of investments
Arkin Holdings' recent investments
Arkin Holdings has made 1 investments in 2026 so far - Stark Power.Here are the most recent investments by Arkin Holdings:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Apr 07, 2026 | Israel | Post IPO | 6060 | [+5] | |
Aug 04, 2025 | Israel | Series A | 3787 | [+5] | |
May 09, 2025 | United States | Series A | 6881 | [+8] | |
Feb 10, 2025 | United States | Series A | 3841 | ||
Feb 04, 2025 | United States | Series B | 1314 | [+7] |
IPOs and Publicly Listed companies in Arkin Holdings' Portfolio
5 of Arkin Holdings' portfolio companies have become public. Werewolf got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Apr 2021 at marketcap of $441M and Oncorus got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $328M.Here are Arkin Holdings' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Apr 30, 2021 | Aug 13, 2020 | Series A | 7952 | |
Oct 02, 2020 | Sep 21, 2018 | Series A | 4552 | |
Apr 08, 2020 | Jan 07, 2019 | Series B | 7342 | |
Jan 23, 2018 | - | - | 8722 | |
May 04, 2017 | - | - | 9877 |
Acquired companies in Arkin Holdings' Portfolio
16 companies from Arkin Holdings' portfolio have been acquired. The most recent acquisition was Validic in Jun 2026 by ChartSpan for $*****.Here are Arkin Holdings' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jun 22, 2026 | Nov 14, 2022 | Series B | 7248 | |
May 18, 2026 | - | - | 7411 | |
Dec 08, 2025 | Aug 16, 2022 | Series B | 1697 | |
Mar 03, 2025 | - | - | 7321 | |
Nov 22, 2023 | - | - | 5771 |
Team profile of Arkin Holdings
Arkin Holdings has a team of 13 members including 5 Partners and 4 Principals located in Israel and United States. Arkin Holdings' team does not sit on the board of any company as of now.Here is a list of top team members in Arkin Holdings:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Israel | - | ||
Partner | New York City | - | ||
Partner | Israel | - | ||
Partner | Los Angeles | - | - | |
Partner | Tel Aviv Yafo | - | ||
Principal | Tel Aviv | - | ||
Principal | Pasadena | - | ||
Principal | Tel Aviv | - | ||
Principal | Israel | - |
Co-investors of Arkin Holdings
Over the past 15 years, 263 investors have co-invested in Arkin Holdings's portfolio companies. This includes funds and angels.
- Invested before Arkin Holdings: Mark Cuban, Lool Ventures and 51 others have invested in rounds before Arkin Holdings. There are 2 companies where Mark Cuban has invested before Arkin Holdings and 1 company where Lool Ventures has invested before Arkin Holdings.
- Top Co-investors of Arkin Holdings: 136 investors entered a company along with Arkin Holdings. These include investors like Pontifax (5 companies).
- Invested after Arkin Holdings: A total of 74 investors have invested in Arkin Holdings's portfolio after their investments. Top Investors include RA Capital Management (2 companies), HBM Healthcare Investments (2 companies) and Sphera Fund (2 companies).
Recent News related to Arkin Holdings
•
Revisto Raises $4 Million in Seed Funding to Revolutionize Pharmaceutical Marketing Compliance with AIBusiness Wire•Nov 18, 2024•Revisto, Live Oak Ventures, Lilly, Tau Ventures and 1 other
•
Honeycomb Insurance: Digital Insurer Company Raises $36 MillionPulse 2.0•May 17, 2024•Honeycomb, Arkin Holdings, Launchbay Capital, Ibex Investors and 2 others
•
Bluejay Therapeutics Secures $182 Million in Series C Financing to Propel Clinical PipelineDrug Development & Delivery•May 09, 2024•Bluejay Therapeutics, Frazier Life Sciences, RA Capital Management, T. Rowe Price and 8 others
•
Honeycomb Insurance grabs $36M Series B from solo VC-led Zeev VenturesStartupNews•May 07, 2024•Honeycomb Insurance, Zeev Ventures, Arkin Holdings, Launchbay Capital and 3 others
•
MPM BioImpact-owned Reunion raises $103M, one of the largest rounds for a psychedelic biotechFierce Biotech•May 02, 2024•Reunion Neuroscience, MPM BioImpact, Novo Holdings, Arkin Holdings and 7 others
•
•
Nocion Therapeutics Raises $62M in Series B FundingContract Pharma•Mar 04, 2024•Nocion Therapeutics, Arkin Holdings, Monograph, F-Prime Capital and 5 others
•
Siftwell Analytics Secures $5.8M for AI-Powered Community Health Plan AnalyticsHIT Consultant•Feb 20, 2024•Siftwell, AlleyCorp, Arkin Holdings, Tau Ventures and 1 other
•
NextPoint Therapeutics Announces Closing of Series B Financing Extension Led by Catalio Capital ManagementBusiness Wire•Feb 14, 2024•NextPoint Therapeutics, Catalio Capital Management, MPM BioImpact, Bayer and 5 others
•
HI-Bio Announces $95 Million Series B Financing to Advance Targeted Therapies for Immune-Mediated DiseasesTullahoma News•Jan 04, 2024•HIBio, Alpha Wave Global, Viking Global Investors, Arkin Holdings and 3 others
